helpline 01494 601 400
10 February 2017

Department of Health stresses commitment to fast access to medication post Brexit

The Department of Health has issued a statement following BBC Radio 4's Today programme this morning (10 February) looking at whether UK patients would face delays in getting new drugs if Britain withdraws from the European Medicines Agency (EMA).

BBC Radio 4 Today programme

You can listen to the broadcast at The news item begins at 1:50:00

 A Department of Health spokesperson said:

“Ensuring patients have timely access to safe, effective medicines is, and always will be a priority for this government – in fact, Brexit brings opportunities in this area, and we will be focused on whether we can secure even faster access to the latest innovations for British patients.

"So we are already taking action to ensure the UK continues to be a world leader and our cross-agency Brexit taskforce is considering the future regulatory roles the MHRA could adopt.”

Epilepsy Society response

Epilepsy Society is currently in touch with the Government to seek further reassurance that there will be no adverse consequences to future epilepsy treatments as a direct result of the Brexit vote.

More information

Read more about the debate over drug delays post Brexit.

Find out more about epilepsy drugs.


Share this article: